5th Feb 2021 12:56
(Sharecast News) - Ongoing safety checks by the UK regulator confirmed the safety of Covid-19 vaccines.
Read more5th Feb 2021 08:05
(Sharecast News) - AstraZeneca said on Friday that its Imfinzi (durvalumab) drug failed to meet its primary endpoint in a Phase III trial for head and neck cancers.
Read more4th Feb 2021 11:27
(Sharecast News) - The UK has launched the first trial in the world that explores mixing different Covid-19 vaccines for the first and second jab.
Read more4th Feb 2021 08:00
(Sharecast News) - AstraZeneca announced on Thursday that 'Forxiga', or dapagliflozin, has been approved in China to reduce the risk of cardiovascular death and hospitalisation for heart failure, in adults with heart failure (NYHA class II-IV) with reduced ejection fraction.
Read more2nd Feb 2021 18:52
(Sharecast News) - Spacing out the doses of AstraZeneca's Covid-19 vaccine by three months raises their effectiveness to 82%, the results of a new study revealed.
Read more1st Feb 2021 13:01
(Sharecast News) - AstraZeneca has agreed to divest its 26.7% stake in US biotechnology company Viela Bio as part of the latter's proposed acquisition by Horizon Therapeutics.
Read more1st Feb 2021 07:34
(Sharecast News) - AstraZeneca is set to supply an extra nine million doses of its Covid-19 vaccine to the European Union after a high-profile row over shortages.
Read more31st Jan 2021 21:49
(Sharecast News) - The UK could help the EU and other nations with coronavirus vaccine supplies even before the domestic vaccination programme has been completed, the international trade secretary, Liz Truss, has said. As ministers sought to smooth relations with Brussels after the EU's much-criticised and swiftly rescinded decision to impose a vaccine border between Northern Ireland and the Republic of Ireland, Truss sought to stress the need for international cooperation. - Guardian
Read more29th Jan 2021 16:41
(Sharecast News) - The European Union drug regulator said on Friday that it has approved the use of AstraZeneca's Covid-19 for use in adults.
Read more29th Jan 2021 10:41
(Sharecast News) - Moderna has told Italy and France they will get fewer vaccine doses than expected in February in a further setback for EU vaccination programmes, according to a report.
Read more12th Jan 2021 09:00
(Sharecast News) - The EU's drugs regulator said it would review a conditional approval application for AstraZeneca and Oxford University's Covid-19 vaccine this month under an accelerated timeline.
Read more6th Jan 2021 07:35
(Sharecast News) - AstraZeneca announced on Wednesday that 'Farxiga', or dapagliflozin, has been granted Priority Review status in the United States for the treatment of new or worsening chronic kidney disease (CKD) in adults with and without type-2 diabetes (T2D).
Read more5th Jan 2021 12:22
(Sharecast News) - Reducing the dosage of currently approved Covid-19 vaccines could pose a public health risk, the Food and Drug Administration said.
Read more30th Dec 2020 11:51
(Sharecast News) - Chinese Covid-19 vaccine developer Sinopharm said it will seek approval from regulators after final stage trials showed a 79% efficacy rate.
Read more30th Dec 2020 07:38
(Sharecast News) - The Oxford University/AstraZeneca Covid-19 vaccine has been approved for use in the UK, with vaccinations set to begin early in the New Year.
Read more